GL1X · GenesisL1 explorer

Research workbench

Structure of omalizumab Fab fragment crystal form 1

Analyse Structure of omalizumab Fab fragment crystal form 1 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4X7S
Type
protein
Length
440 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epididymis luminal protein 214; Ig kappa chain C region
Pockets
5 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HEpididymis luminal protein 214protein2228% helix, 50% strand—
LIg kappa chain C regionprotein2186% helix, 54% strand—

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16060.620.7462empty
22330.550.7839empty
3510.490.8720empty
4530.260.7421empty
5510.250.7314empty

Interfaces

1 interface between chains.

  • H–L · 1928 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4X7S · Structure of omalizumab Fab fragment crystal form 1 · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.